Isabel Healthcare to Exhibit at ENGAGE14, Greenway Health’s Annual Users Conference

Published on:

Ann Arbor, MI September 04, 2014 -- Isabel Healthcare will exhibit at the Greenway Users Conference- Engage 2014, Booth 414, on September 4-7, 2014 in Dallas, Texas.

Isabel Healthcare provides a diagnosis decision support and knowledge management solution to help clinicians broaden their differential and get to the right diagnosis and treatment plan efficiently. Isabel assists in providing information to clinicians as part of their workflow and integrated with the EMR, empowering caregivers with information for efficient diagnosis and treatment decisions.

“We are very excited to share the latest version of Isabel with Greenway Health clients and physician users at ENGAGE14,” said Don Bauman, CEO of Isabel Healthcare in North America. “Isabel not only provides diagnosis support when needed but also assists with achieving Meaningful Use CDS goals.”

About Isabel Healthcare

Isabel Healthcare Inc. was founded in 2000 by Jason Maude and is named after Maude’s daughter who almost died after a potentially fatal illness was not recognized. For over 10 years, Isabel Healthcare has provided the Isabel diagnosis decision support system to hospitals, physician practices and individual physicians and gained peer reviewed validation and unmatched experience. Today, Isabel is the only diagnosis checklist system fully integrated with EMR and is used by thousands of physicians, nurse practitioners, physician assistants and students worldwide, providing diagnostic support and education by broadening their differential diagnostic considerations. Connect with us at, 734-332-0612 or http://www.Isabelhealthcare.com or to learn more.

About Greenway Health

Greenway Health™ delivers the clinical, financial and administrative solutions healthcare providers need to effectively manage the delivery of quality care and improve health outcomes for patient populations. For over 30 years, Greenway has offered smarter solutions that help providers succeed in an evolving value-based healthcare system. Greenway’s clinically driven revenue cycle management™ services and comprehensive suite of interoperable solutions improve financial performance and automate clinical and administrative workflows, so medical providers can spend time on patients instead of paperwork. For more information, visit http://www.greenwayhealth.com or call (866) 242-3805. Follow Greenway on Facebook, Twitter and LinkedIn.

Cited marks are trademarks or registered trademarks of Greenway Health, LLC or its affiliates. Other product or company names are the property of their respective owners.

Related Content

Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software
Leveraging machine learning to rapidly create clinical AI algorithms
How medication reconciliation data consolidation in the EHR enables better patient care
How are the best in KLAS Health IT vendor rankings created?

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup